MR-proANP and MR-proADM for risk stratification of patients with acute chest pain

Conclusions
MR-proADM and MR-proANP are predictors of future cardiovascular events in patients presenting with acute chest pain and might facilitate the choice of treatment in those patients complementary to established risk scores.

Source: Heart - February 18, 2013 Category: Cardiology Authors: Tzikas, S., Keller, T., Ojeda, F. M., Zeller, T., Wild, P. S., Lubos, E., Kunde, J., Baldus, S., Bickel, C., Lackner, K. J., Munzel, T. F., Blankenberg, S. Tags: Drugs: cardiovascular system, Acute coronary syndromes, Epidemiology Biomarkers and heart disease Source Type: research